
### [MONDO:0002305](http://purl.obolibrary.org/obo/MONDO_0002305)
**Label:** thrombophilia

**Subclasses:** [MONDO:0013144](http://purl.obolibrary.org/obo/MONDO_0013144) (antithrombin III deficiency), [MONDO:0012872](http://purl.obolibrary.org/obo/MONDO_0012872) (THPH9), [MONDO:0008560](http://purl.obolibrary.org/obo/MONDO_0008560) (thrombophilia due to Activated protein c resistance), [MONDO:0010122](http://purl.obolibrary.org/obo/MONDO_0010122) (congenital thrombotic thrombocytopenic purpura), [MONDO:0012860](http://purl.obolibrary.org/obo/MONDO_0012860) (thrombophilia due to protein c deficiency, autosomal recessive), [MONDO:0018896](http://purl.obolibrary.org/obo/MONDO_0018896) (thrombotic thrombocytopenic purpura), [MONDO:0019740](http://purl.obolibrary.org/obo/MONDO_0019740) (acquired thrombotic thrombocytopenic purpura), [MONDO:0013791](http://purl.obolibrary.org/obo/MONDO_0013791) (thrombophilia due to protein S deficiency, autosomal recessive), [MONDO:0013143](http://purl.obolibrary.org/obo/MONDO_0013143) (hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency), [MONDO:0008316](http://purl.obolibrary.org/obo/MONDO_0008316) (thrombophilia due to protein c deficiency, autosomal dominant), [MONDO:0008559](http://purl.obolibrary.org/obo/MONDO_0008559) (thrombophilia due to Thrombin defect), [MONDO:0012876](http://purl.obolibrary.org/obo/MONDO_0012876) (Heparin cofactor 2 deficiency), [MONDO:0010432](http://purl.obolibrary.org/obo/MONDO_0010432) (thrombophilia, X-linked, due to factor 9 defect), [MONDO:0013775](http://purl.obolibrary.org/obo/MONDO_0013775) (thrombomodulin-related bleeding disorder), [MONDO:0012868](http://purl.obolibrary.org/obo/MONDO_0012868) (protein S acquired deficiency), 

**Corr. equiv. classes:** [OMIM:188055](http://purl.obolibrary.org/obo/OMIM_188055), [Orphanet:217467](http://www.orpha.net/ORDO/Orphanet_217467), [OMIM:188050](http://purl.obolibrary.org/obo/OMIM_188050), [Orphanet:436169](http://www.orpha.net/ORDO/Orphanet_436169), [OMIM:614486](http://purl.obolibrary.org/obo/OMIM_614486), [OMIM:612356](http://purl.obolibrary.org/obo/OMIM_612356), [OMIM:176860](http://purl.obolibrary.org/obo/OMIM_176860), [OMIM:614514](http://purl.obolibrary.org/obo/OMIM_614514), [OMIM:274150](http://purl.obolibrary.org/obo/OMIM_274150), [OMIM:612336](http://purl.obolibrary.org/obo/OMIM_612336), [OMIM:300807](http://purl.obolibrary.org/obo/OMIM_300807), [OMIM:613116](http://purl.obolibrary.org/obo/OMIM_613116), [Orphanet:93583](http://www.orpha.net/ORDO/Orphanet_93583), [Orphanet:26349](http://www.orpha.net/ORDO/Orphanet_26349), [OMIM:612348](http://purl.obolibrary.org/obo/OMIM_612348), [OMIM:612304](http://purl.obolibrary.org/obo/OMIM_612304), [OMIM:613118](http://purl.obolibrary.org/obo/OMIM_613118), [Orphanet:82](http://www.orpha.net/ORDO/Orphanet_82), [Orphanet:54057](http://www.orpha.net/ORDO/Orphanet_54057), [Orphanet:93585](http://www.orpha.net/ORDO/Orphanet_93585), 

**Class expressions from DL-Learner:**

- [HP:0001928](http://purl.obolibrary.org/obo/HP_0001928) (Abnormality of coagulation) and [HP:0002625](http://purl.obolibrary.org/obo/HP_0002625) (Deep venous thrombosis) 67.50%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002625](http://purl.obolibrary.org/obo/HP_0002625) (Deep venous thrombosis) 67.14%
- [HP:0002625](http://purl.obolibrary.org/obo/HP_0002625) (Deep venous thrombosis) 65.80%
- [HP:0002625](http://purl.obolibrary.org/obo/HP_0002625) (Deep venous thrombosis) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 65.00%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0002625](http://purl.obolibrary.org/obo/HP_0002625) (Deep venous thrombosis) 65.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001928](http://purl.obolibrary.org/obo/HP_0001928) (Abnormality of coagulation) and [HP:0002625](http://purl.obolibrary.org/obo/HP_0002625) (Deep venous thrombosis) 65.00%
- [HP:0005305](http://purl.obolibrary.org/obo/HP_0005305) (Cerebral venous thrombosis) and [HP:0030875](http://purl.obolibrary.org/obo/HP_0030875) (Abnormality of pulmonary circulation) 62.50%
- [HP:0005305](http://purl.obolibrary.org/obo/HP_0005305) (Cerebral venous thrombosis) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) 62.50%
- [HP:0002625](http://purl.obolibrary.org/obo/HP_0002625) (Deep venous thrombosis) and [HP:0003256](http://purl.obolibrary.org/obo/HP_0003256) (Abnormality of the coagulation cascade) 62.50%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0005305](http://purl.obolibrary.org/obo/HP_0005305) (Cerebral venous thrombosis) 62.50%
- [HP:0002204](http://purl.obolibrary.org/obo/HP_0002204) (Pulmonary embolism) and [HP:0005305](http://purl.obolibrary.org/obo/HP_0005305) (Cerebral venous thrombosis) 62.50%
- [HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality) and [HP:0005305](http://purl.obolibrary.org/obo/HP_0005305) (Cerebral venous thrombosis) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) 62.50%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0005305](http://purl.obolibrary.org/obo/HP_0005305) (Cerebral venous thrombosis) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 62.50%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality) and [HP:0005305](http://purl.obolibrary.org/obo/HP_0005305) (Cerebral venous thrombosis) 62.50%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0005305](http://purl.obolibrary.org/obo/HP_0005305) (Cerebral venous thrombosis) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) 62.50%


